Clinical trial
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
NCT00249977 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00249977 |
|---|---|
| Title | Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan |
| Official title | Phase I Study Of Capecitabine in Combination With Cisplatin and Irinotecan in Patients With Advanced Malignancies. |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors, Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine in Combination with Cisplatin and Irinotecan |
| Enrollment | 21 |
| Start date | Apr 1, 2003 |
| Primary completion | Aug 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Nov 7, 2005 |
| Last update posted | Jan 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: